Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZD0473 (picoplatin) in Second-Line Non-Small Cell Lung Cancer
NCT00021008Phase 2Unknown
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of picoplatin in non-small cell lung cancer (NSCLC), sponsored by UCLA Jonsson Comprehensive Cancer Center. Primary endpoints: Overall Survival, Time to Disease Progression and 2 more. Status: unknown.
02
Drugs
picoplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00021008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00021008.